| scholarly article | Q13442814 |
| P50 | author | Matthias Endres | Q15441092 |
| P2093 | author name string | Ulrich Laufs | |
| P433 | issue | 11 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2708-2711 | |
| P577 | publication date | 2004-09-16 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Effects of statins on endothelium and signaling mechanisms | |
| P478 | volume | 35 |
| Q64377263 | A novel mechanism of action for statins against diabetes-induced oxidative stress |
| Q36697677 | A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction |
| Q46915325 | A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain |
| Q34707087 | Age-dependent accumulation of ubiquitinated 2',3'-cyclic nucleotide 3'-phosphodiesterase in myelin lipid rafts |
| Q36693396 | Alzheimer's disease and cholesterol: the fat connection |
| Q33358995 | Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats |
| Q34429244 | Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy |
| Q37031349 | Are pleiotropic effects of statins real? |
| Q37393748 | Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. |
| Q46685352 | Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats |
| Q38172676 | Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management |
| Q64111957 | CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica |
| Q30366554 | Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals |
| Q33357329 | Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside |
| Q40624431 | Commentary Statin discontinuation: counterbalancing the benefits with the potential risks |
| Q37867298 | Current and Future Treatment Considerations in the Management of Aneurysmal Subarachnoid Hemorrhage |
| Q36059383 | Daming capsule restores endothelial dysfunction induced by high-fat diet |
| Q33403016 | Diabetic retinopathy: current management and experimental therapeutic targets. |
| Q34354040 | Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. |
| Q51772543 | Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis. |
| Q34173180 | Effects of Statins on Skeletal Muscle: A Perspective for Physical Therapists |
| Q42124567 | Effects of atorvastatin on nitrate tolerance in diabetic rats |
| Q36349732 | Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage |
| Q43111572 | Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells |
| Q35053761 | Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats |
| Q53413627 | Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes |
| Q38006716 | Evidence for the efficacy of statins in animal stroke models: a meta-analysis |
| Q41489698 | Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood |
| Q39705806 | HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A. |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q37941943 | Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? |
| Q34474278 | Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis |
| Q42068602 | Lovastatin inhibits the thrombin-induced loss of barrier integrity in bovine corneal endothelium |
| Q46798716 | Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil |
| Q54586862 | Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft |
| Q37081593 | NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for Prevention |
| Q36711178 | NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway. |
| Q38694219 | New molecular insights in diabetic nephropathy |
| Q37820092 | Oxidative stress in early diabetic nephropathy: fueling the fire |
| Q59034810 | Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy |
| Q37154822 | Potential therapeutic role of statins in neurological disorders. |
| Q36629849 | Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase. |
| Q39948284 | Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling |
| Q26782005 | Rho GTPases: Novel Players in the Regulation of the DNA Damage Response? |
| Q50497309 | Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats |
| Q33867269 | Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein |
| Q36876792 | Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model. |
| Q54468758 | Short-term simvastatin treatment has no effect on plasma cytokine response in a human in vivo model of low-grade inflammation. |
| Q38063315 | Sickle Cell Disease, Vasculopathy, and Therapeutics |
| Q37378861 | Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage |
| Q37811981 | Statin Rebound or Withdrawal Syndrome: Does It Exist? |
| Q36847283 | Statin therapy in South-Asian patients: clinical implications beyond lipid lowering? |
| Q36994718 | Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage |
| Q34999332 | Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis |
| Q36582678 | Statin withdrawal: clinical implications and molecular mechanisms |
| Q89496650 | Statins Induce a DAF-16/Foxo-dependent Longevity Phenotype via JNK-1 through Mevalonate Depletion in C. elegans |
| Q36641478 | Statins Protect the Blood Brain Barrier Acutely after Experimental Intracerebral Hemorrhage |
| Q81623503 | Statins and stroke |
| Q38166072 | Statins and the autonomic nervous system |
| Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
| Q41544765 | Statins enhance expression of growth factors and activate the PI3K/Akt-mediated signaling pathway after experimental intracerebral hemorrhage |
| Q37907293 | Statins in hemorrhagic stroke |
| Q57398738 | Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro |
| Q34662787 | Statins: a perspective for left ventricular hypertrophy treatment |
| Q26738400 | Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases |
| Q37110204 | The Effect of Pulsatility Index on Infarct Volume in Acute Lacunar Stroke |
| Q35017735 | The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase. |
| Q38248109 | The good and bad effects of statins on insulin sensitivity and secretion |
| Q52646637 | The impact of statins on FGF-2-stimulated human umbilical vein endothelial cells |
| Q37495621 | Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway |
| Q36106811 | Treatment with statins in the acute phase of ischemic stroke. |
| Q34973956 | Vascular nitric oxide: formation and function |
| Q43280593 | Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection. |
Search more.